4D Molecular Therapeutics (FDMT) Q4 2024 Earnings

Nov 13Confirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.79
-0.74
-0.68
-0.63

Details

Expected EPS
-0.6759
Actual EPS
-0.79
Surprise EPS
-0.11
Surprise Percent
-16.88%

Description

⁨4D Molecular Therapeutics⁩ (⁦FDMT⁩) has reported earnings of ⁦-0.79⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts